A Study to Evaluate the Efficacy and Safety of Once-Weekly MET097 in Adults With Obesity or Overweight and T2DM

Clinical trial NCT06897202 · COMPLETED

Trial details

NCT number: NCT06897202
Sponsor: Pfizer
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Obesity in Diabetes Type 2 Diabetes Mellitus (T2DM)

Start date: 2025-03-14
Primary completion: 2025-12-29
Enrollment: 133

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.